Help your patients who are prescribed XCOPRI® (cenobamate tablets) CV get started and stay on therapy as appropriate
The SK life science navigator program may assist you and your staff with the following*:
• Identifying if XCOPRI is covered by your patient’s insurance plan
• Providing prior authorization information for XCOPRI if it is required for the insurance plan
• Supplying free product to your patients who are*†:
– Initiating therapy
– Experiencing coverage delays with their insurance
– Rendered uninsured or underinsured
• Sending refill and appointment reminders to your patients via text message, if requested‡
Enrolling your patients is simple
Just 2 simple tests to enroll a patient in the SK life science navigator program:
- A healthcare provider (HCP) needs to complete the SK life science navigator program Enrollment Form, including§:
- Patient information
- Pharmacy insurance information
- HCP information
- Patient diagnosis
- Prescription information
- HCP signature
- Patients must sign the Patient Authorization section
- Completed forms can be faxed to SK life science navigator at 877-436-4188, or submit via electronic portal
*Eligibility requirements will apply. Please visit www.SKLSINavigator.com for more information.
†Program not available to hospital inpatients, long-term care patients, group medical home patients, Veterans Affairs, or the Department of Defense.
‡Standard text messaging rates may apply.
§If prescribing from New York, Iowa, or any state that requires e-prescribing, please complete the enrollment form and contact SK life science navigator at 866-756-2844 (866-SK-NAVIG).
XCOPRI drug-drug interactions flashcard
XCOPRI Setting Expectations Tearpad
S.T.E.P.S.—A discussion guide for patients with epilepsy
Standing for Seizures, Treatment, Emotional Impact, Personal Goals, and Safety—The S.T.E.P.S. Discussion Guide was designed to help foster a stronger relationship between patients and their care teams and help those affected by epilepsy reach their goals.
The guide is based on the national Seize the Truth about Epilepsy Perceptions (STEP) Survey. SK Life Science, Inc., partnered with Kantar Health to compile responses from 400 adult patients, 201 caregivers, and 258 healthcare providers to help better understand the current state of epilepsy in the United States.
connect with an XCOPRI Representative
Want to learn more about XCOPRI and/or receive updates from SK life science?
All fields required.